Volatility and Risk
Atlantic International has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Atlantic International’s rivals have a beta of 1.14, indicating that their average stock price is 14% more volatile than the S&P 500.
Institutional & Insider Ownership
60.6% of shares of all “Help supply services” companies are owned by institutional investors. 22.3% of Atlantic International shares are owned by insiders. Comparatively, 16.9% of shares of all “Help supply services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Atlantic International and its rivals gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Atlantic International | $80,000.00 | -$5.63 million | -0.30 |
Atlantic International Competitors | $3.15 billion | $43.38 million | -15.24 |
Profitability
This table compares Atlantic International and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Atlantic International | N/A | -298.20% | -42.32% |
Atlantic International Competitors | -0.66% | 15.30% | 4.24% |
Summary
Atlantic International rivals beat Atlantic International on 5 of the 9 factors compared.
Atlantic International Company Profile
Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.
Receive News & Ratings for Atlantic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlantic International and related companies with MarketBeat.com's FREE daily email newsletter.